Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 11 studies | 38% ± 24% | |
| ciliated cell | 11 studies | 27% ± 10% | |
| retinal cone cell | 8 studies | 64% ± 19% | |
| GABAergic neuron | 7 studies | 41% ± 19% | |
| interneuron | 6 studies | 40% ± 21% | |
| retinal rod cell | 6 studies | 34% ± 14% | |
| neuron | 5 studies | 31% ± 9% | |
| retina horizontal cell | 5 studies | 23% ± 11% | |
| astrocyte | 5 studies | 33% ± 10% | |
| oligodendrocyte | 5 studies | 25% ± 7% | |
| epithelial cell | 4 studies | 17% ± 2% | |
| oligodendrocyte precursor cell | 4 studies | 20% ± 4% | |
| retinal ganglion cell | 4 studies | 32% ± 11% | |
| GABAergic interneuron | 3 studies | 26% ± 13% | |
| granule cell | 3 studies | 20% ± 2% | |
| ependymal cell | 3 studies | 40% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 1831.22 | 2642 / 2642 | 100% | 9.32 | 702 / 705 |
| adrenal gland | 100% | 698.06 | 258 / 258 | 97% | 5.86 | 222 / 230 |
| breast | 98% | 445.82 | 452 / 459 | 90% | 3.11 | 1007 / 1118 |
| thymus | 99% | 451.07 | 649 / 653 | 88% | 2.05 | 532 / 605 |
| intestine | 100% | 614.83 | 965 / 966 | 87% | 2.93 | 457 / 527 |
| kidney | 99% | 504.08 | 88 / 89 | 86% | 2.10 | 773 / 901 |
| prostate | 96% | 404.22 | 236 / 245 | 80% | 1.65 | 401 / 502 |
| ovary | 98% | 411.14 | 176 / 180 | 78% | 1.79 | 335 / 430 |
| stomach | 89% | 333.56 | 319 / 359 | 86% | 3.35 | 245 / 286 |
| lung | 99% | 588.78 | 572 / 578 | 73% | 1.69 | 842 / 1155 |
| pancreas | 86% | 305.60 | 281 / 328 | 83% | 2.25 | 148 / 178 |
| uterus | 98% | 681.45 | 167 / 170 | 66% | 1.71 | 304 / 459 |
| esophagus | 76% | 330.35 | 1091 / 1445 | 87% | 3.00 | 160 / 183 |
| skin | 76% | 319.26 | 1372 / 1809 | 78% | 2.07 | 370 / 472 |
| bladder | 90% | 406.10 | 19 / 21 | 52% | 1.51 | 264 / 504 |
| muscle | 100% | 1170.98 | 803 / 803 | 0% | 0 | 0 / 0 |
| adipose | 97% | 469.38 | 1166 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 97% | 397.00 | 1292 / 1335 | 0% | 0 | 0 / 0 |
| heart | 90% | 370.62 | 772 / 861 | 0% | 0 | 0 / 0 |
| spleen | 85% | 247.20 | 205 / 241 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 83% | 3.40 | 24 / 29 |
| liver | 35% | 88.92 | 78 / 226 | 23% | 0.45 | 95 / 406 |
| eye | 0% | 0 | 0 / 0 | 36% | 0.67 | 29 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 36% | 0.84 | 16 / 45 |
| peripheral blood | 30% | 603.79 | 278 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0008150 | Biological process | biological_process |
| GO_0005575 | Cellular component | cellular_component |
| GO_0003674 | Molecular function | molecular_function |
| Gene name | FSD1L |
| Protein name | Fibronectin type III and SPRY domain containing 1 like FSD1-like protein (Coiled-coil domain-containing protein 10) (FSD1 N-terminal-like protein) FSD1L protein (Fibronectin type III and SPRY domain containing 1 like) |
| Synonyms | FSD1CL CSDUFD1 CCDC10 FSD1NL |
| Description | |
| Accessions | Q8N450 ENST00000469022.5 [Q9BXM9-3] F8W946 C9JD05 A0A0C4DG97 ENST00000495708.5 ENST00000374707.1 ENST00000481272.6 [Q9BXM9-1] ENST00000394926.7 Q9BXM9 ENST00000484973.5 |